MedPath

Pentam 300

Pentam® 300 (pentamidine isethionate for injection)

Approved
Approval ID

cc2b635e-4840-4dc3-a177-5484371680e8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 13, 2022

Manufacturers
FDA

Fresenius Kabi USA, LLC

DUNS: 608775388

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PENTAMIDINE ISETHIONATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63323-113
Application NumberNDA019264
Product Classification
M
Marketing Category
C73594
G
Generic Name
PENTAMIDINE ISETHIONATE
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateSeptember 13, 2022
FDA Product Classification

INGREDIENTS (1)

PENTAMIDINE ISETHIONATEActive
Quantity: 300 mg in 3 mL
Code: V2P3K60DA2
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.